Steve England, Chief Science Officer
In his current role is CSO at 3Scan, a company defining the future of digital tissue pathology, using large volume, high-throughput imaging combined with full-service data analysis. 3Scan uses its patented Knife-Edge Scanning Microscope (KESM) to produce digital 3D tissue models at micron-scale resolution, thereby transforming a manual, analog, and qualitative field into an automated, digitized and quantitative medical science.
He is also an experienced professional in the early stages of drug discovery and development -from target identification, through project initiation up to proof of concept, gained at a number of large Pharma. Throughout his career He has managed both large and small groups of scientists and established a number of successful external collaborations with both academics and small companies.